Roser Ferrer Costa I'm the Head of Clinical Biochemistry Service at Hospital's Clinical Laboratories and co-chief of Clinical Biochemistry Group, Pharmaceutical Vehiculation and VHIR Research Therapy. I lead a team of professionals in clinical biochemistry, developing care, teaching and research, with a project towards the highest excellence. I am a PhD in Biomedicine for UB, a specialist in the area of knowledge of clinical biochemistry of hormones and a master's degree in Health Institutions Management and currently an Associate Professor of the UAB. Instituciones de las que forman parte Jefe de grupo Bioquímica Clínica, Vehiculización de Fármacos y Terapia Vall Hebron Institut de Recerca Jefe de Servicio Bioquímica Serveis transversals LinkedIn Twitter Orcid Roser Ferrer Costa LinkedIn Twitter Orcid Instituciones de las que forman parte Jefe de grupo Bioquímica Clínica, Vehiculización de Fármacos y Terapia Vall Hebron Institut de Recerca Jefe de Servicio Bioquímica Serveis transversals I'm the Head of Clinical Biochemistry Service at Hospital's Clinical Laboratories and co-chief of Clinical Biochemistry Group, Pharmaceutical Vehiculation and VHIR Research Therapy. I lead a team of professionals in clinical biochemistry, developing care, teaching and research, with a project towards the highest excellence. I am a PhD in Biomedicine for UB, a specialist in the area of knowledge of clinical biochemistry of hormones and a master's degree in Health Institutions Management and currently an Associate Professor of the UAB.
Healthcare activity: Since 2007 I have been working at the University Hospital, where I trained as a specialist in Clinical Biochemistry (2003). I am a trained pharmacist and until 2019 I was responsible for the Hormone Process (Endocrin Pathology) of the same Service and later Head of Section of the Automated Laboratory. Since 2023, I have been Head of Clinical Biochemistry Service. The Clinical Biochemistry Service is part of the Clinical Laboratories of the Vall d'Hebron University Hospital, which also provides coverage for the entire population, with pubic health care, of the city of Barcelona (1.5 million people). In 2019 I completed my master's degree in Health Institutions Management, I have training in healthcare processes and specialisation in automation, concepts that I try to apply in my usual practice and in the Service. Finally, I am the secretary of the hospital's In Vitro Diagnostic Commission. Research activity: I am a Doctor of Biomedicine from the University of Barcelona (2015) and co-chief of Clinical Biochemistry Group, Vehiculation of Pharmacists and Therapy Research from the Research Institute of the Vall d'Hebron University Hospital since 2023. In recent years I have been actively involved in different publications of the Service itself and in collaboration with research groups and hospital services. Attached to the eCore Personalized Medicine, Innovative Diagnostics, Molecular Imaging . Digital Health of VHIR. I am president of the Catalan Clinical Laboratory Science Association (since June 2021) and member of the Hormone Commission (since 2011) and of the Executive Committee (since 2018) of the Spanish Society of Medicine of the Laboratory (SEQCML). Docent Activity: I am currently Associate Professor of the Autonomous University of the Department of Biochemistry and Molecular Biology, Medicine Biochemistry Unit. I am participating in the postgraduate doctoral thesis management of the Biochemistry Service.
Líneas de investigación Determinación de hormonas con alta sensibilidad IP: Roser Ferrer Costa, Marina Giralt Arnaiz Laboratory management y automatización IP: Ernesto Casis Saenz, Roser Ferrer Costa, Clara Ramírez Serra Anàlisi de dades massives (big data), explotació de dades i mostres als Laboratoris Clínics IP: Roser Ferrer Costa Proyectos Estudio multicéntrico de la reactividad de PSA de las vesículas extracelulares frente a inmunoensayos comerciales IP: Roser Ferrer Costa Colaboradores: - Entidad financiadora: FUNDACIÓN JOSÉ LUIS CASTAÑO Financiación: Referencia: SECQ/FERRER/2023 Duración: 01/01/2024 - 31/12/2026 Evaluation of an innovative strategy based on nanoparticles-loaded hydrogels as a safe and sustained intraperitoneal chemotherapy in mucinous adenocarcinomas IP: Fernanda Raquel Da Silva Andrade Colaboradores: Roser Ferrer Costa, Julia German Cortes, Angels Alcina Mila, Diana Fernandes de Rafael Entidad financiadora: Asociación Española Contra el Cáncer Financiación: 10000 Referencia: SNRGS247164DASI Duración: 01/06/2024 - 31/05/2026 TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas IP: Begoña Benito Villabriga Colaboradores: Carmen Escudero Iriarte, Laia Ventura i Expósito, Susana Otero Romero, Ibane Abasolo Olaortua, Ignacio Ferreira González, José Antonio Barrabés Riu, Carlos Nos Llopis, Pablo Velasco Puyó, Jose Fernando Rodríguez Palomares, María Rosario Pérez- Torres Lobato, Sunny Malhotra Sareen, Perez Dueñas, Belen, Jaume Sastre Garriga, Joan López Hellin, Antonia Sambola Ayala, Jordi Rio Izquierdo, Nuria Rivas Gandara, Jordi Perez Rodon, Aroa Soriano Fernández, Manuel Comabella Lopez, Antonio Rodríguez Sinovas, Gisela Teixido Tura, Antonia Pijuan Domenech, Roser Ferrer Costa, Joaquin Seras Franzoso, Carmen Tur Gomez, Maria Cristina Díaz de Heredia Rubio, Laia Yañez Bisbe, Julia German Cortes, Maria Jose Pérez García, Miguel Segura Ginard, Diego Baranda Martínez-Abasca, Cristina Auger Acosta, Neus Bellera Gotarda, Herena Eixarch Ahufinger, M Mar Mañu Pereira, Deborah Pareto Onghena, Lorena Valero Arrese, Aitor Uribarri Gonzalez, Jordi Bañeras Rius, Alex Rovira Cañellas, Mar Tintore Subirana, Bruno García del Blanco, Maria Teresa Salcedo Allende, Marisol Ruiz Meana, Ana Belén Méndez Fernández, Xavier Montalban Gairín, Simon Schwartz Navarro, Anna Llort Sales, Carmen Espejo Ruiz, Raquel Hladun Alvaro, Angels Alcina Mila, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Ana Zabalza de Torres, Ariadna Boloix Amenós, Marc Miquel Moltó Abad, Javier Inserte Igual, Elizabeth Pando Rau, Gabriela Guillén Burrieza, Cazurro Gutierrez, Ana Laura, Gómez Andrés, David, Alvaro Cobo Calvo, Alvaro Calabuig Goena, Joaquin Castillo Justribo, Lydia Dux-Santoy Hurtado, Lucas Moreno Martín-Retortillo, Andres Miguez Gonzalez, Josep Roma Castanyer, Laura Dos Subirá, Nicolás Miguel Fissolo, Maria Nazarena Pizzi, Tian Tian, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael, Andrea Guala Entidad financiadora: Instituto de Salud Carlos III Financiación: 2494527.53 Referencia: FORT23/00034 Duración: 01/01/2024 - 31/12/2027 (HEPAST) - Estrategias de terapia genica para controlar la infeccion por los virus de la Hepatitis B y Delta basada en el estudio de las cuasiespecies virales por secuenciación masiva IP: - Colaboradores: Roser Ferrer Costa Entidad financiadora: Ministerio de Ciencia e Innovación-MICINN Financiación: 157300 Referencia: PID2021-126447OB-I00 Duración: 01/09/2022 - 01/09/2025 Paginación Página actual 1 Página 2 Página 3 Siguiente página › Última página »
